Covid-19: Mylan’s remdesivir will be available to patients in India in July at ₹4,800
- Mylan to launch generic remdesivir version in India at $64 per 100 mg vial, while Gilead has priced it at $2,340 per patient for wealthier nations
- Drug has been approved in India for treatment of suspected or lab-confirmed Covid-19 cases, Mylan NV says